Michael Krämer

7.4k citations

103 papers · 2.9k indexed · h-index 31

Impact in

Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Hematology 62
- Acute Myeloid Leukemia Research 48
- Hematopoietic Stem Cell Transplantation 19
- Multiple Myeloma Research and Treatments 9
- Chronic Myeloid Leukemia Treatments 8
Genetics 22
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13

Co-authors: Gerhard Ehninger (60 shared papers)Martin Bornhäuser (60 shared papers)Christoph Röllig (39 shared papers)Christian Thiede (32 shared papers)Markus Schaich (30 shared papers)Malte von Bonin (15 shared papers)Johannes Schetelig (25 shared papers)Frank Kroschinsky (16 shared papers)
Journals: Blood (26 papers)Journal of Clinical Oncology (5 papers)Leukemia (3 papers)Blood Advances (3 papers)Annals of Oncology (3 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Michael Krämer

99 papers receiving 2.8k citations

Peers

Countries citing papers authored by Michael Krämer

Since Specialization

Citations

This map shows the geographic impact of Michael Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Krämer more than expected).

Fields of papers citing papers by Michael Krämer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Krämer. The network helps show where Michael Krämer may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Krämer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Krämer Line = papers co-authored together Michael Krämer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia Blood Cancer Journal ·Armin Ehninger, Michael Krämer, Christoph Röllig, Christian Thiede, Martin Bornhäuser, Malte von Bonin, Martin Wermke, Anja Feldmann, Michael Bachmann, Gerhard Ehninger, Uta Oelschlägel, (unknown)	2014	260
2	Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study The Lancet ·Hannes Wandt, Kerstin Schaefer‐Eckart, Knut Wendelin, Bettina Pilz, Martin Wilhelm, M. Thalheimer, Ulrich Mahlknecht, Anthony D. Ho, Markus Schaich, Michael Krämer, Martin Kaufmann, Lothar Leimer, Rainer Schwerdtfeger, Roland Conradi, Gottfried Dölken, Anne F. Klenner, Mathias Hänel, Regina Herbst, Christian Junghanß, Gerhard Ehninger	2012	210
3	Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System Journal of Clinical Oncology ·Christoph Röllig, Martin Bornhäuser, Christian Thiede, Franziska Taube, Michael Krämer, Brigitte Mohr, Walter E. Aulitzky, H. Bodenstein, Hans‐Joachim Tischler, Reingard Stuhlmann, Ulrich S. Schuler, Friedrich Stölzel, Malte von Bonin, Hannes Wandt, Kerstin Schäfer‐Eckart, Markus Schaich, Gerhard Ehninger	2011	161
4	Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors Blood ·Kristina Hölig, Michael Krämer, Frank Kroschinsky, Martin Bornhäuser, Thilo Mengling, Alexander H. Schmidt, Claudia Rutt, Gerhard Ehninger	2009	154
5	The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML Blood ·Nona Shayegi, Michael Krämer, Martin Bornhäuser, Markus Schaich, Johannes Schetelig, Uwe Platzbecker, Christoph Röllig, Caroline Heiderich, Olfert Landt, Gerhard Ehninger, Christian Thiede	2013	136
6	A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial Blood ·Christoph Röllig, Christian Thiede, Martin Gramatzki, Walter E. Aulitzky, H. Bodenstein, Martin Bornhäuser, Uwe Platzbecker, Reingard Stuhlmann, Ulrich S. Schuler, Silke Soucek, Michael Krämer, Brigitte Mohr, Uta Oelschlaegel, Friedrich Stölzel, Malte von Bonin, Martin Wermke, Hannes Wandt, Gerhard Ehninger, Markus Schaich, (unknown)	2010	118
7	A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients Annals of Oncology ·Markus Schaich, L. Kestel, Markus Pfirrmann, Katja Robel, Thomas Illmer, Michael Krämer, Claudia Dill, Gerhard Ehninger, Gabriele Schackert, Dietmar Krex	2008	111
8	Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie Journal of Clinical Oncology ·Eray Goekkurt, Salah‐Eddin Al‐Batran, Jörg T. Hartmann, U. Mogck, Gunter Schuch, Michael Krämer, E. Jaeger, Carsten Bokemeyer, Gerhard Ehninger, Jan Stoehlmacher	2009	103
9	Delineating physiologic defensive reactivity in the domain of self-report: phenotypic and etiologic structure of dispositional fear Psychological Medicine ·Michael Krämer, Christopher J. Patrick, Robert F. Krueger, Marianna Gasperi	2011	82
10	Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome Stem Cells ·Felix von Dalowski, Michael Krämer, Martin Wermke, Rebekka Wehner, Christoph Röllig, Nael Alakel, Friedrich Stölzel, Stefani Parmentier, Katja Sockel, Mathias Krech, Marc Schmitz, Uwe Platzbecker, Johannes Schetelig, Martin Bornhäuser, Malte von Bonin	2015	69
11	Clostridium septicum aortitis: Report of two cases and review of the literature Journal of Vascular Surgery ·Christopher W. Seder, Michael Krämer, Graham W. Long, Maciej Uzieblo, Charles J. Shanley, Paul Bove	2009	69
12	Cytarabine Dose of 36 g/m² Compared With 12 g/m² Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study Journal of Clinical Oncology ·Markus Schaich, Christoph Röllig, Silke Soucek, Michael Krämer, Christian Thiede, Brigitte Mohr, Uta Oelschlaegel, Norbert Schmitz, Reingard Stuhlmann, Hannes Wandt, Kerstin Schäfer‐Eckart, Walter E. Aulitzky, Martin Kaufmann, H. Bodenstein, J. Tischler, Anthony D. Ho, Alwin Krämer, Martin Bornhäuser, Johannes Schetelig, Gerhard Ehninger	2011	67
13	Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience. PubMed ·D J Ross, P F Waters, Michael S. Levine, Michael Krämer, S A Ruzevich, Robin Martin Kåss	1998	63
14	Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears Leukemia ·Jan‐Niklas Eckardt, Jan Moritz Middeke, Sebastian Riechert, Tim Schmittmann, Anas Shekh Sulaiman, Michael Krämer, Katja Sockel, Frank Kroschinsky, Ulrich S. Schuler, Johannes Schetelig, Christoph Röllig, Christian Thiede, Karsten Wendt, Martin Bornhäuser	2021	60
15	Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors Haematologica ·S. Parmentier, Johannes Schetelig, Kerstin Lorenz, Michael Krämer, Robin Ireland, Ulrich S. Schuler, Rainer Ordemann, Gabi Rall, Markus Schaich, Martin Bornhäuser, G. Ehninger, Frank Kroschinsky	2011	59
16	Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia Journal of Clinical Oncology ·Tilmann Bochtler, Friedrich Stölzel, Christoph E. Heilig, Christina Kunz, Brigitte Mohr, Anna Jauch, Johannes W.G. Janssen, Michael Krämer, Axel Benner, Martin Bornhäuser, Anthony D. Ho, Gerhard Ehninger, Markus Schaich, Alwin Krämer	2013	51
17	Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia Blood ·Tilmann Bochtler, Martin Granzow, Friedrich Stölzel, Christina Kunz, Brigitte Mohr, Mutlu Kartal‐Kaess, Katrin Hinderhofer, Christoph E. Heilig, Michael Krämer, Christian Thiede, Volker Endris, Martina Kirchner, Albrecht Stenzinger, Axel Benner, Martin Bornhäuser, Gerhard Ehninger, Anthony D. Ho, Anna Jauch, Alwin Krämer	2017	50
18	Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial The Lancet Oncology ·Markus Pfirrmann, Gerhard Ehninger, Christian Thiede, Martin Bornhäuser, Michael Krämer, Christoph Röllig, Joerg Hasford, Markus Schaich	2011	44
19	Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial The Lancet Haematology ·Martin Wermke, Julia Eckoldt, Katharina S. Götze, Stefan Klein, Gesine Bug, Liesbeth C. de Wreede, Michael Krämer, Friedrich Stölzel, Malte von Bonin, Johannes Schetelig, Michael Laniado, Verena Plodeck, Wolf‐Karsten Hofmann, Gerhard Ehninger, Martin Bornhäuser, Dominik Wolf‎, Igor Theurl, Uwe Platzbecker	2018	42
20	Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia Cancer Management and Research ·Nael Alakel, Friedrich Stölzel, Brigitte Mohr, Michael Krämer, Uta Oelschlägel, Christoph Röllig, Martin Bornhäuser, Gerhard Ehninger, Markus Schaich	2017	42

About Michael Krämer

Michael Krämer is a scholar working on Hematology, Genetics, Emergency Medicine, Oncology and Orthopedics and Sports Medicine, having authored 103 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (48 papers), Hematopoietic Stem Cell Transplantation (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Multiple Myeloma Research and Treatments (9 papers), Hematological disorders and diagnostics (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Retinoids in leukemia and cellular processes (7 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (534 citations), Transplantation (82 citations), Oncology (774 citations) and Biochemistry (146 citations). Michael Krämer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Gerhard Ehninger, Martin Bornhäuser, Christoph Röllig, Christian Thiede, Markus Schaich, Malte von Bonin, Johannes Schetelig, Frank Kroschinsky, Friedrich Stölzel and Martin Wermke. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Blood Advances and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact